LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

DaCapo Brainsciences

DaCapo Brainscience’s (“DaCapo’s”) mission is to develop some of the first disease-modifying therapies for neurodegenerative diseases. To do this DaCapo combines novel techniques, developed by our founders, in neuroscience, machine learning and stem-cell technologies, to identify and validate new targets and new categories of disease within the larger CNS universe.

  • Matthew Peck COO